Target intelligence / Profile preview

RNA, U6 small nuclear 227, pseudogene (RNU6-227P)

Target
RNU6-227P
Molecular classification
Other, Pseudogene, Small nuclear RNA (snRNA)
01

Overview

RNU6-227P is a **pseudogene copy** of the gene encoding U6 small nuclear RNA (snRNA), an RNA component essential for the spliceosome, which catalyzes the removal of introns from pre-mRNA in eukaryotes. While **U6 snRNA** itself is highly conserved and crucial for splicing, **RNU6-227P** represents a non-functional, processed copy (pseudogene) and is not believed to encode a functional product or participate in biological processes[1][5]. The presence of multiple U6-derived pseudogenes is common in vertebrate genomes due to the evolutionary importance of splicing, but individual pseudogenes like RNU6-227P are not considered therapeutic targets, are not associated with disease, and do not exhibit known regulatory or functional activity[1][5]. **Key points:** - This entity is a *pseudogene*, not an active snRNA or protein, and therefore is not a "target" in the sense of therapeutics or drug discovery. - There is no evidence of functional properties, roles in splicing, or disease association for RNU6-227P itself[1][5]. - If you are interested in the **functional snRNA active in the spliceosome**, the appropriate canonical name is "U6 small nuclear RNA" or "U6 snRNA", not this pseudogene[5]. **Notes on incorrectness:** - This entry is *not* an active gene, protein, or therapeutic target. - The target appears correctly named as a pseudogene, but using it as a drug target or functional molecular entity would be incorrect[1]. - If a functional snRNA is needed, reference the active "U6 small nuclear RNA" instead. Pseudogenes like RNU6-227P do not yield functional products or have known pharmacological relevance[1][5].

Other names
RNU6-227P

Beyond the preview

Go deeper on RNA, U6 small nuclear 227, pseudogene (RNU6-227P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 227, pseudogene (RNU6-227P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call